Oncoinvent ASA (OSE: ONCIN) a clinical stage 2 radiopharmaceutical company developing novel radiopharmaceutical therapies against cancer, announces its fourth quarter 2024 results today. During the 4 ...
Press release, quarterly report and presentation will be available on www.oncoinvent.com. 10.00 CET Live streamed of quarterly presentation in English. A webcast will be available for everyone to view ...
Some of the Type 00 concept’s most edgy design elements will be toned down for production. It’s no secret that the radical Jaguar Type 00 concept won’t make it to production as a sleek two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback